What are the benefits and risks of tamoxifen for breast cancer prevention in people at moderate risk?

Tamoxifen is effective in reducing breast cancer risk in moderate-risk populations, but it comes with significant risks such as endometrial cancer and thromboembolic events. Clinical decisions should weigh these factors and include regular monitoring.

Authors

Tripdatabase

Publication Details

Journal: Zenodo (CERN European Organization for Nuclear Research)
Published: 2026-10-26
DOI: https://doi.org/10.5281/zenodo.23661093
Primary Topic: Estrogen and related hormone effects
Type: article
Field-Weighted Citation Impact: 0.00

Controls

|||

ALL TIME

JAN

FEB

MAR

APR

MAY

JUN

JUL

AUG

SEP

OCT

article

What are the benefits and risks of tamoxifen for breast cancer prevention in people at moderate risk?

Tripdatabase

Oct 26, 2026

Zenodo (CERN European Organization for Nuclear Research)

Estrogen and related hormone effects

article

What are the benefits and risks of tamoxifen for breast cancer prevention in people at moderate risk?

Tripdatabase

October 26, 2026article en

Abstract

Zenodo (CERN European Organization for Nuclear Research)

Openalex Percentile: Top 14%

Estrogen and related hormone effects

DOI Open Access PDF OpenAlex

AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Laika access coming soon

What are the benefits and risks of tamoxifen for breast cancer prevention in people at moderate risk? — Tripdatabase · Zenodo (CERN European Organization for Nuclear Research) (2026) | TGRS Research Map | TGRS